Stock performance
Search documents
Archer-Daniels-Midland’s Quarterly Earnings Preview: What You Need to Know
Yahoo Finance· 2026-01-06 15:36
Company Overview - Archer-Daniels-Midland Company (ADM) is a major food processing and agricultural commodities trading corporation headquartered in Chicago, Illinois, with a market cap of $28.4 billion [1] Earnings Expectations - Analysts expect ADM to report a Q4 profit of $0.84 per share, which represents a decline of 26.3% from $1.14 per share reported in the same quarter last year [2] - For fiscal year 2025, the expected EPS is $3.40, down 28.3% from $4.74 in the previous year, but a rebound of 24.1% to $4.22 per share is anticipated in fiscal 2026 [3] Stock Performance - ADM's stock has increased by 19% over the past 52 weeks, outperforming the S&P 500 Index's gains of 16.2% during the same period [4] - The stock experienced upward movement in 2025 due to earnings results that exceeded analyst expectations and positive sentiment regarding operational improvements, with a 2.7% increase on January 2, 2026 [5] Analyst Ratings - The consensus rating for ADM is "Hold," with one analyst recommending "Strong Buy," five suggesting "Hold," two advising "Moderate Sell," and three giving "Strong Sell" ratings [6]
Tesla stock erases early gains: why investors turned sour on Q4 deliveries
Invezz· 2026-01-02 15:35
Core Insights - Tesla experienced a second consecutive annual decline in vehicle sales, indicating a potential trend in decreasing demand for its products [1] Group 1: Company Performance - The market initially seemed unaffected by Tesla's weaker delivery numbers, suggesting a temporary investor confidence [1] - However, selling pressure increased as investors began to reassess the implications of the declining sales figures [1]
These stocks fell hard in 2025, but analysts see as much as 65% upside for them in 2026
MarketWatch· 2025-12-29 14:59
Core Insights - The S&P 500 has achieved a return of 19.3% year-to-date, indicating strong overall market performance [1] - Despite the positive performance of the S&P 500, numerous individual stocks are experiencing significant declines projected for 2025 [1] Group 1 - The S&P 500's year-to-date return stands at 19.3% [1] - A considerable number of stocks are forecasted to show notable declines in 2025 [1]
Paychex (PAYX) Reports Q2 Earnings: What Key Metrics Have to Say
ZACKS· 2025-12-22 15:31
Core Insights - Paychex reported revenue of $1.56 billion for the quarter ended November 2025, reflecting an 18.3% increase year-over-year and a surprise of +0.22% over the Zacks Consensus Estimate of $1.55 billion [1] - Earnings per share (EPS) for the quarter was $1.26, up from $1.14 in the same quarter last year, with an EPS surprise of +1.61% compared to the consensus estimate of $1.24 [1] Financial Performance Metrics - Average investment balance for funds held for clients was $5.35 billion, exceeding the three-analyst average estimate of $5.22 billion [4] - Average interest rates earned on funds held for clients was 3.5%, slightly above the three-analyst average estimate of 3.4% [4] - Average investment balance for corporate cash equivalents and investments was $1.68 billion, surpassing the $1.55 billion average estimate based on two analysts [4] - Average interest rates earned on corporate cash equivalents and investments was 3.9%, below the two-analyst average estimate of 4.1% [4] - Revenue from Management Solutions was $1.17 billion, slightly below the $1.18 billion average estimate from five analysts, but represented a +21.1% year-over-year change [4] - Revenue from interest on funds held for clients was $54.3 million, exceeding the $45.65 million estimated by five analysts, marking a +50.4% change year-over-year [4] - Total service revenue was $1.5 billion, slightly below the $1.51 billion estimated by five analysts, with a +17.4% year-over-year change [4] - Revenue from PEO and Insurance Solutions was $336.9 million, above the five-analyst average estimate of $330.83 million, representing a +6% year-over-year change [4] Stock Performance - Shares of Paychex have returned +0.7% over the past month, underperforming the Zacks S&P 500 composite's +3% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]
Nike, Insmed, And Arm Are Among Top 10 Large Cap Losers Last Week (Dec. 15-Dec. 19): Are the Others in Your Portfolio? - ARM Holdings (NASDAQ:ARM), BitMine Immersion (AMEX:BMNR), Insmed (NASDAQ:INSM),
Benzinga· 2025-12-21 15:01
Group 1: Stock Performance - Nike, Inc. (NYSE:NKE) decreased by 12.81% due to a 17% decline in Greater China sales in Q2 and multiple analysts lowering their price forecasts [1] - Arm Holdings plc (NASDAQ:ARM) fell by 9.77% after Goldman Sachs downgraded the stock from Neutral to Sell, lowering the price forecast from $160 to $120, and B of A Securities reduced it from $205 to $145 [2] - Insmed Incorporated (NASDAQ:INSM) decreased by 11.37% this week [3] - ServiceNow, Inc. (NYSE:NOW) fell by 0.78% after the Phase 2b BiRCh study did not meet its efficacy endpoints [3] - BitMine Immersion Technologies, Inc. (AMEX:BMNR) decreased by 9.15% amid volatility in Bitcoin prices [4] - Lennar Corporation (NYSE:LEN) fell by 9.94% following a fourth-quarter earnings miss and multiple analysts lowering their price forecasts [4] - Coupang, Inc. (NYSE:CPNG) decreased by 8.52% this week [4] - Marathon Petroleum Corporation (NYSE:MPC) slumped by 9.42% due to a CFO transition announcement [4] - Entegris, Inc. (NASDAQ:ENTG) fell by 5.90% after Goldman Sachs downgraded the stock from Neutral to Sell, lowering the price target from $88 to $75 [5] - Phillips 66 (NYSE:PSX) fell by 8.84% as energy stocks traded lower due to Russia-Ukraine ceasefire hopes affecting oil prices and warmer weather forecasts impacting natural gas [5]
Why Is Jack In The Box (JACK) Up 27% Since Last Earnings Report?
ZACKS· 2025-12-19 17:31
Core Viewpoint - Jack In The Box reported mixed Q4 fiscal 2025 results, with earnings missing estimates while revenues exceeded expectations, indicating potential challenges ahead for the company [2][3]. Financial Performance - Adjusted EPS for Q4 was 30 cents, missing the Zacks Consensus Estimate of 46 cents, and down 74.1% from $1.16 in the prior-year quarter [3]. - Quarterly revenues reached $326.2 million, surpassing the consensus mark of $321 million, but declined 6.6% year-over-year due to lower sales volume and Del Taco refranchising [3]. Franchise and Sales Metrics - Franchise rental revenues decreased 7.6% year-over-year to $80.7 million, while franchise royalties and other revenues fell 4.4% to $52.1 million [4]. - Company-owned same-store sales decreased 5.3%, and same-store sales at franchised stores dropped 7.6%, indicating a decline in overall sales performance [5]. Operating Margins - Total restaurant-level adjusted margin was 16.1%, down from 18.5% in the prior-year quarter, while total franchise level margin decreased to 38.9% from 40.4% [7]. Balance Sheet Overview - As of September 28, 2025, cash totaled $51.5 million, an increase from $24.7 million a year prior, while long-term debt was $1.67 billion, slightly down from $1.7 billion [8]. Future Outlook - For fiscal 2026, management anticipates adjusted EBITDA between $225-$240 million and expects same-store sales to be flat or down 1% compared to 2025 [10]. - The company has a Zacks Rank of 5 (Strong Sell), indicating expectations of below-average returns in the coming months [13]. Industry Comparison - Jack In The Box operates within the Zacks Retail - Restaurants industry, where competitor McDonald's has shown a 5.1% gain over the past month, highlighting contrasting performance trends [14].
Humana Inc. (NYSE:HUM) Overview: Stock Performance and Market Outlook
Financial Modeling Prep· 2025-12-18 18:06
Core Viewpoint - Humana Inc. is a prominent health insurance provider in the U.S., recently rated "Underperform" by Morgan Stanley, which has lowered its price target for the company [1][6]. Financial Performance - Morgan Stanley adjusted Humana's price target from $277 to $262, while the stock was priced at $260.28, reflecting a slight increase of $2.12 or 0.82% [2][6]. - Humana's stock has fluctuated between $256.35 and $266.08 during the day, with a yearly high of $315.35 and a low of $206.87. The company's market capitalization is approximately $31.3 billion [4][6]. Contracts and Partnerships - The U.S. Defense Department awarded Humana a $7.3 billion contract for health care and administrative support services, indicating a strong relationship with the Pentagon and potential positive impacts on future financial performance [3][5][6]. Market Activity - Today's trading volume for Humana is 1,073,203 shares, indicating significant investor interest despite the "Underperform" rating from Morgan Stanley [5][6].
10 Worst-Performing Stocks of 2025
Yahoo Finance· 2025-12-17 15:00
Core Viewpoint - The stock market is expected to achieve another double-digit percentage gain in 2025, with the S&P 500 index showing a year-to-date gain of 16.81% as of December 5, despite significant declines in several individual stocks [1]. Group 1: Worst-Performing Stocks - Fiserv (FISV) has seen a decline of approximately 70%, attributed to a drastic cut in its full-year revenue forecast and slowing growth in its merchant-services segment [3]. - The Trade Desk (TTD) is down approximately 67%, facing decreased revenues due to competition from major players like Amazon, leading investors to view the stock as overvalued [4]. - Deckers Outdoor (DECK) has dropped around 57%, with slowing growth expectations and pressure on discretionary consumer spending impacting its well-known brands, UGG and Hoka [5]. - Gartner (IT) is down approximately 52%, with its valuation at $17 billion, facing cyclical pressure as companies reduce spending on advisory services during economic uncertainty [6].
Snap-on Stock: Is SNA Underperforming the Industrial Sector?
Yahoo Finance· 2025-12-15 12:27
Company Overview - Snap-on Incorporated (SNA) is based in Kenosha, Wisconsin, and specializes in building and selling professional tools, equipment, diagnostics, and repair solutions, serving automotive, aerospace, energy, and transportation markets through various channels [1] Stock Performance - SNA stock is currently trading approximately 4.1% below its January high of $365.78 and has gained 5.2% over the past three months, outperforming the State Street Industrial Select Sector SPDR ETF (XLI), which rose 3.4% [2] - Over the past 52 weeks, SNA stock has decreased by 1.4%, but it has posted a 3.3% gain year-to-date (YTD). In contrast, XLI has increased by 13.8% over the same period and nearly 19% YTD, indicating Snap-on's relative underperformance [4] Technical Analysis - Technically, SNA stock has maintained a steady position, remaining above its 50-day moving average of $339.90 and its 200-day moving average of $328.49 since early December, which signals improving sentiment [5] Recent Financial Performance - On October 16, SNA shares surged nearly 3.5% following a stronger-than-expected Q3 fiscal 2025 report. The Repair Systems & Information group contributed to a 3.8% year-over-year increase in net sales to $1.19 billion, surpassing analyst estimates of $1.15 billion. Net earnings rose by 5.7% to $265.4 million, with adjusted EPS at $4.71 per share, exceeding forecasts of $4.59 [6] Competitive Landscape - SNA's competitor, Kennametal Inc. (KMT), has gained 8.8% over the past 52 weeks and 22.1% YTD, indicating that Snap-on has room to catch up [7] - Analysts maintain a positive outlook for SNA, with a "Moderate Buy" consensus rating from 10 analysts and a mean price target of $365.29, suggesting a premium of 4.1% to current levels [7]
Nordson (NDSN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2025-12-11 00:01
Core Insights - Nordson reported revenue of $751.82 million for the quarter ended October 2025, reflecting a year-over-year increase of 1% and an EPS of $3.03 compared to $2.78 a year ago [1] - The revenue fell short of the Zacks Consensus Estimate of $769 million, resulting in a surprise of -2.23%, while the EPS exceeded the consensus estimate of $2.93 by 3.41% [1] Financial Performance - Net Sales for Industrial Precision Solutions were $361.71 million, slightly above the average estimate of $360.05 million, but represented a year-over-year decline of 7.8% [4] - Net Sales for Advanced Technology Solutions reached $170.61 million, below the average estimate of $180.73 million, showing a year-over-year increase of 12.2% [4] - Net Sales for Medical and Fluid Solutions amounted to $219.5 million, also below the average estimate of $228.03 million, with a year-over-year increase of 9.6% [4] Stock Performance - Over the past month, Nordson's shares have returned -1.3%, contrasting with the Zacks S&P 500 composite's increase of 1.8% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]